<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01872286</url>
  </required_header>
  <id_info>
    <org_study_id>capsule-1</org_study_id>
    <nct_id>NCT01872286</nct_id>
  </id_info>
  <brief_title>Comparison of the Frequency-altering AKE-1 Capsule and Pillcam SB2</brief_title>
  <official_title>A Double-center Randomized Head-to-head Comparison of the Frequency-altering AKE-1 Capsule and Pillcam SB2</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Changhai Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Second Military Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ministry of Education, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Changhai Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Capsule endoscopy has been shown to be the first-line endoscopic procedure for small bowel
      disease. This study was aimed to compare the performance between the frequency-altering AKE-1
      capsule and the Pillcam SB2 in patients with suspected small bowel disease.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>judgement of normal or abnormal of gastrointestinal tract</measure>
    <time_frame>5 weeks after the examination</time_frame>
    <description>If a lesion is detected by capsule endoscopy in gastrointestinal tract in a patient, the result will be judged as abnormal.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>complete small-bowel examination rate</measure>
    <time_frame>5 weeks after the examination</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>diagnostic yield</measure>
    <time_frame>5 weeks after the examination</time_frame>
    <description>The finding that could explain the symptom and resulted in clinical impact was considered as diagnosis.Diagnostic yield of a capsule endoscopy is the proportion of patients with positive diagnosis over total patients.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>total recording time</measure>
    <time_frame>5 weeks after the examination</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>gastric transit time</measure>
    <time_frame>the comparison was completed 5 weeks after the examination</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>small-bowel transit time</measure>
    <time_frame>the comparison was completed 5 weeks after the examination</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>total number of images captured</measure>
    <time_frame>the comparison was completed 5 weeks after the examination</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>number of adverse events as a measure of safety</measure>
    <time_frame>2 months after the examination</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">53</enrollment>
  <condition>Intestinal Diseases</condition>
  <condition>Gastrointestinal Hemorrhage</condition>
  <arm_group>
    <arm_group_label>Pillcam SB2 first</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients were assigned to swallow PSB first, followed by the AKE</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AKE-1 first</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients were assigned to swallow AKE first, followed by the PSB</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AKE-1</intervention_name>
    <arm_group_label>Pillcam SB2 first</arm_group_label>
    <arm_group_label>AKE-1 first</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pillcam SB2</intervention_name>
    <arm_group_label>Pillcam SB2 first</arm_group_label>
    <arm_group_label>AKE-1 first</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  obscure gastrointestinal bleeding

          -  chronic diarrhea

          -  suspected Crohn's disease

          -  chronic abdominal pain

          -  neoplastic lesions of small bowel

        Exclusion Criteria:

          -  patients with any contraindication to capsule endoscopy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhao-Shen Li, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wuhan Union Hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430022</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shanghai Changhai Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200433</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Liao Z, Gao R, Xu C, Li ZS. Indications and detection, completion, and retention rates of small-bowel capsule endoscopy: a systematic review. Gastrointest Endosc. 2010 Feb;71(2):280-6. doi: 10.1016/j.gie.2009.09.031. Review.</citation>
    <PMID>20152309</PMID>
  </reference>
  <reference>
    <citation>Cave DR, Fleischer DE, Leighton JA, Faigel DO, Heigh RI, Sharma VK, Gostout CJ, Rajan E, Mergener K, Foley A, Lee M, Bhattacharya K. A multicenter randomized comparison of the Endocapsule and the Pillcam SB. Gastrointest Endosc. 2008 Sep;68(3):487-94. doi: 10.1016/j.gie.2007.12.037. Epub 2008 Apr 14.</citation>
    <PMID>18410941</PMID>
  </reference>
  <reference>
    <citation>Dolak W, Kulnigg-Dabsch S, Evstatiev R, Gasche C, Trauner M, Püspök A. A randomized head-to-head study of small-bowel imaging comparing MiroCam and EndoCapsule. Endoscopy. 2012 Nov;44(11):1012-20. doi: 10.1055/s-0032-1310158. Epub 2012 Aug 28.</citation>
    <PMID>22930176</PMID>
  </reference>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 4, 2013</study_first_submitted>
  <study_first_submitted_qc>June 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 7, 2013</study_first_posted>
  <last_update_submitted>February 28, 2014</last_update_submitted>
  <last_update_submitted_qc>February 28, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 3, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Changhai Hospital</investigator_affiliation>
    <investigator_full_name>Zhaoshen Li</investigator_full_name>
    <investigator_title>Director of Gastroenterology Dept.</investigator_title>
  </responsible_party>
  <keyword>Capsule Endoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Gastrointestinal Hemorrhage</mesh_term>
    <mesh_term>Intestinal Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

